To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Podcast: Listen
Hesham Gayar, M.D., a board certified radiation oncologist, is Medical Director for the McLaren Proton Therapy Center, part of the Karmanos Cancer Network. He also serves as Vice President for the Particle Therapy Co-Operative Group (PTCOG) -North American Chapter and as a board member and Steering Committee member for PTCOG worldwide. His involvement in proton therapy also includes membership on the Executive Committee of the Proton Collaborative Group Medical Societies and as a member of the World Forum on Particle Therapy Strategic Planning for 2030. He holds numerous leadership positions at McLaren, including serving as chairman of the Department of Radiation Oncology at McLaren Flint, Associate Medical Director of the Karmanos Cancer Institutes at McLaren Flint and Lapeer, Chairman of the Research Advisory Board at McLaren Health Care, and Chairman of the Karmanos Cancer Institute Clinical Leadership Council.
Dr. Gayar earned his medical degree from the Alexandria School of Science in Egypt and completed a residency at St. Vincent’s Hospital in New York and a fellowship at Ohio State University. He also completed training in proton therapy at the Paul Scherrer Institute. He is past president of the Board of Directors of the Genesee County Medical Society, a RTOG Principal Investigator with the Michigan State Medical Society, an American College of Surgeons Liaison Physician and a member of the Scientific Advisory Board for the Cancer Terminator Foundation.
The second annual Prostate Cancer Awareness Night with the Detroit Tigers, Karmanos Cancer Institute and McLaren Health Care , the official health care system of the Tigers, was a smashing success as fans celebrated the lives of survivors near and far. Decorated with a blue theme to build awareness for prostate cancer, Comerica Park welcomed hundreds of prostate cancer survivors as the Tigers defeated the San Diego Padres 12 to 4 in game one of the series. “Partnering with the Tigers for such a large ev...
“If somebody came to me as I did to my friend who went through all of this [proton therapy treatments], I would definitely recommend that if it’s [proton therapy] an option you can do – I would say proton therapy is very good.” After a diagnosis of prostate cancer , many men begin researching and looking for the best option to continue their quality of life. Many prostate cancer patients at the McLaren Proton Therapy Center , part of the Karmanos Cancer Network, are learning about proton therapy from me...
"It was presented as a low side effect form of treatment and I certainly experienced little side effects from it." A three-year journey for Joshua Story ends with a milestone and a symbolic bell ringing. The 26-year-old from Bay City has finished proton therapy to treat cancer that started in his parotid gland. He also happens to be the 400 th patient at the McLaren Proton Therapy Center . “It feels great to have completed it. Hopefully, I won’t have to come here again,” Story said with a laugh. “I had ...
Hersham Gayar, M.D., discusses the advantage of McLaren's Proton Therapy Center, which is part of the Karmanos Cancer Network.